{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T23:49:18Z","timestamp":1794354558564,"version":"4.9.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T00:00:00Z","timestamp":1675728000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anais Brasileiros de Dermatologia"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.abd.2022.09.005","type":"journal-article","created":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T08:06:25Z","timestamp":1677657985000},"page":"355-372","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"title":["Cutaneous lupus erythematosus: a review of etiopathogenic, clinical, diagnostic and therapeutic aspects"],"prefix":"10.1016","volume":"98","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9172-3639","authenticated-orcid":false,"given":"Everton Carlos Siviero do","family":"Vale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7883-5986","authenticated-orcid":false,"given":"Lucas Campos","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.abd.2022.09.005_bib0005","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s41584-019-0272-0","article-title":"Cutaneous lupus erythematosus: new insights into pathogenesis and therapeutic strategies","volume":"15","author":"Wenzel","year":"2019","journal-title":"Nat Rev Rheumatol."},{"key":"10.1016\/j.abd.2022.09.005_bib0010","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6610509","article-title":"Cutaneous manifestations of \u201clupus\u201d: systemic lupus erythematosus and beyond","volume":"2021","author":"Cooper","year":"2021","journal-title":"Int J Rheumatol."},{"key":"10.1016\/j.abd.2022.09.005_bib0015","first-page":"216","article-title":"Cutaneous lupus erythematosus: clinico-pathologic correlation","volume":"153","author":"Filotico","year":"2018","journal-title":"G Ital Dermatol Venereol."},{"key":"10.1016\/j.abd.2022.09.005_bib0020","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11882-020-00906-8","article-title":"Cutaneous lupus erythematosus: progress and challenges","volume":"20","author":"Petty","year":"2020","journal-title":"Curr Allergy Asthma Rep."},{"key":"10.1016\/j.abd.2022.09.005_bib0025","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2147\/JMDH.S179623","article-title":"A review of cutaneous lupus erythematosus: improving outcomes with a multidisciplinary approach","volume":"12","author":"Jarrett","year":"2019","journal-title":"J Multidiscip Healthc."},{"key":"10.1016\/j.abd.2022.09.005_bib0030","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ijwd.2019.07.004","article-title":"Cutaneous lupus erythematosus: a review of the literature","volume":"5","author":"Blake","year":"2019","journal-title":"Int J Womens Dermatol."},{"key":"10.1016\/j.abd.2022.09.005_bib0035","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.ad.2013.04.005","article-title":"A quality-of-life study of cutaneous lupus erythematosus","volume":"104","author":"Batalla","year":"2013","journal-title":"Actas Dermosifiliogr."},{"key":"10.1016\/j.abd.2022.09.005_bib0040","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.abd.2022.09.005_bib0045","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/art.40930","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus","volume":"71","author":"Aringer","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.abd.2022.09.005_bib0050","first-page":"1","article-title":"The performance of different classification criteria for systemic lupus erythematosus in a real-world rheumatology department","volume":"00","author":"Tan","year":"2022","journal-title":"Rheumatology (Oxford)."},{"key":"10.1016\/j.abd.2022.09.005_bib0055","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s12016-017-8627-2","article-title":"The cutaneous spectrum of lupus erythematosus","volume":"53","author":"Ribero","year":"2017","journal-title":"Clin Rev Allergy Immunol."},{"key":"10.1016\/j.abd.2022.09.005_bib0060","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s40257-016-0173-9","article-title":"Cutaneous lupus erythematosus: an update on pathogenesis, diagnosis and treatment","volume":"17","author":"Hejazi","year":"2016","journal-title":"Am J Clin Dermatol."},{"key":"10.1016\/j.abd.2022.09.005_bib0065","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1001\/jamadermatol.2020.1698","article-title":"Creation and validation of classification criteria for discoid lupus erythematosus","volume":"156","author":"Elman","year":"2020","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.abd.2022.09.005_bib0070","first-page":"81","article-title":"Cutaneous lupus erythematosus: current and future pathogenesis-directed therapies","volume":"93","author":"Little","year":"2020","journal-title":"Yale J Biol Med."},{"key":"10.1016\/j.abd.2022.09.005_bib0075","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/joim.12057","article-title":"Cutaneous lupus erythematosus: clinical aspects and molecular pathogenesis","volume":"273","author":"Oke","year":"2013","journal-title":"J Intern Med."},{"key":"10.1016\/j.abd.2022.09.005_bib0080","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11926-020-00893-9","article-title":"An update on the pathogenesis of skin damage in lupus","volume":"22","author":"Li","year":"2020","journal-title":"Curr Rheumatol Rep."},{"key":"10.1016\/j.abd.2022.09.005_bib0085","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.3389\/fimmu.2020.01353","article-title":"Current insights in cutaneous lupus erythematosus immunopathogenesis","volume":"11","author":"Garelli","year":"2020","journal-title":"Front Immunol."},{"key":"10.1016\/j.abd.2022.09.005_bib0090","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/BOR.0000000000000770","article-title":"Immunopathogenesis of skin injury in systemic lupus erythematosus","volume":"33","author":"Hile","year":"2021","journal-title":"Curr Opin Rheumatol."},{"key":"10.1016\/j.abd.2022.09.005_bib0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2018.07.007","article-title":"A comprehensive review of immune-mediated dermatopathology in systemic lupus erythematosus","volume":"93","author":"Li","year":"2018","journal-title":"J Autoimmun."},{"key":"10.1016\/j.abd.2022.09.005_bib0100","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/s13075-021-02614-8","article-title":"The prevalence of oral mucosal lesions and related factors in systemic lupus erythematosus patients","volume":"23","author":"Kudsi","year":"2021","journal-title":"Arthritis Res Ther."},{"key":"10.1016\/j.abd.2022.09.005_bib0105","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1111\/ced.14648","article-title":"Toxic epidermal necrolysis-like lupus","volume":"46","author":"Roberts","year":"2021","journal-title":"Clin Exp Dermatol."},{"key":"10.1016\/j.abd.2022.09.005_bib0110","first-page":"376","article-title":"Oral lesions in lupus erythematosus: correlation with cutaneous lesions","volume":"18","author":"Nico","year":"2008","journal-title":"Eur J Dermatol."},{"key":"10.1016\/j.abd.2022.09.005_bib0115","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/17512433.2020.1698290","article-title":"Cutaneous lupus erythematosus induced by drugs - novel insights","volume":"13","author":"Borucki","year":"2020","journal-title":"Expert Rev Clin Pharmacol."},{"key":"10.1016\/j.abd.2022.09.005_bib0120","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/BOR.0000000000000522","article-title":"Drug-induced lupus erythematosus: an update on drugs and mechanisms","volume":"30","author":"He","year":"2018","journal-title":"Curr Opin Rheumatol."},{"key":"10.1016\/j.abd.2022.09.005_bib0125","article-title":"An update in drug-induced subacute cutaneous lupus erythematosus","volume":"23","author":"Michaelis","year":"2017","journal-title":"Dermatol Online J."},{"key":"10.1016\/j.abd.2022.09.005_bib0130","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.annder.2021.02.006","article-title":"Cutaneous drug-induced lupus erythematosus: clinical and immunological characteristics and update on new associated drugs","volume":"148","author":"Bataille","year":"2021","journal-title":"Ann Dermatol Venereol."},{"key":"10.1016\/j.abd.2022.09.005_bib0135","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1177\/0961203317691369","article-title":"Trigger factors of cutaneous lupus erythematosus: a review of current literature","volume":"26","author":"Szcz\u0119ch","year":"2017","journal-title":"Lupus."},{"key":"10.1016\/j.abd.2022.09.005_bib0140","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1177\/0961203311430513","article-title":"The last word on the so-called\u2019 Rowell\u2019s syndrome\u2019?","volume":"21","author":"Antiga","year":"2012","journal-title":"Lupus."},{"key":"10.1016\/j.abd.2022.09.005_bib0145","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1515\/jpm-2020-0543","article-title":"Neonatal lupus erythematosus - practical guidelines","volume":"49","author":"Derdulska","year":"2021","journal-title":"J Perinat Med."},{"key":"10.1016\/j.abd.2022.09.005_bib0150","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.mcna.2021.04.011","article-title":"Recognition and management of cutaneous connective tissue diseases","volume":"105","author":"Kus","year":"2021","journal-title":"Med Clin North Am."},{"key":"10.1016\/j.abd.2022.09.005_bib0155","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.jaad.2020.09.087","article-title":"Development of chronic cutaneous lupus erythematosus during biologic therapy: a systematic review","volume":"84","author":"Mirali","year":"2021","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.abd.2022.09.005_bib0160","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11845-017-1622-z","article-title":"Oral manifestations of lupus","volume":"187","author":"Menzies","year":"2018","journal-title":"Ir J Med Sci."},{"key":"10.1016\/j.abd.2022.09.005_bib0165","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1177\/0961203313492243","article-title":"Lupus erythematosus\/lichen planus overlap syndrome: successful treatment with acitretin","volume":"22","author":"Lospinoso","year":"2013","journal-title":"Lupus."},{"key":"10.1016\/j.abd.2022.09.005_bib0170","article-title":"Seven-year itch: a perplexing case of lichen planus-lupus erythematosus overlap syndrome","volume":"24","author":"Schmitz","year":"2018","journal-title":"Dermatol Online J."},{"key":"10.1016\/j.abd.2022.09.005_bib0175","doi-asserted-by":"crossref","first-page":"e509","DOI":"10.1111\/ijd.15553","article-title":"Association of chilblain lupus and anti-Ro\/SSA and anti-La\/SSB antibodies: a study of 30 cases","volume":"60","author":"Canu","year":"2021","journal-title":"Int J Dermatol."},{"key":"10.1016\/j.abd.2022.09.005_bib0180","article-title":"Chilblains in immune mediated inflammatory diseases: a review","volume":"12","author":"Dubey","year":"2022","journal-title":"Rheumatology (Oxford)."},{"key":"10.1016\/j.abd.2022.09.005_bib0185","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.jdcr.2020.06.009","article-title":"Comedonal variant of chronic cutaneous lupus erythematosus causing mutilation of the earlobe","volume":"6","author":"Cozzani","year":"2020","journal-title":"JAAD Case Rep."},{"key":"10.1016\/j.abd.2022.09.005_bib0190","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ad.2019.07.013","article-title":"Comedonic lupus: an unusual presentation of cutaneous lupus","volume":"112","author":"Chess\u00e9","year":"2021","journal-title":"Actas Dermosifiliogr (Engl Ed)."},{"key":"10.1016\/j.abd.2022.09.005_bib0195","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.abd.2022.04.003","article-title":"Comedogenic lupus: a rare variant of chronic cutaneous lupus erythematosus - case series","volume":"98","author":"Garcia","year":"2023","journal-title":"An Bras Dermatol."},{"key":"10.1016\/j.abd.2022.09.005_bib0200","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2147\/CCID.S166723","article-title":"Lupus erythematosus tumidus: clinical perspectives","volume":"12","author":"Patsinakidis","year":"2019","journal-title":"Clin Cosmet Investig Dermatol."},{"key":"10.1016\/j.abd.2022.09.005_bib0205","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1365-2133.2009.09401.x","article-title":"Lupus erythematosus tumidus is a separate subtype of cutaneous lupus erythematosus","volume":"162","author":"Schmitt","year":"2010","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.abd.2022.09.005_bib0210","series-title":"Dermatoses bolhosas autoimunes","first-page":"119","article-title":"L\u00fapus eritematoso sist\u00eamico bolhoso","author":"Aoki","year":"2016"},{"key":"10.1016\/j.abd.2022.09.005_bib0215","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.semarthrit.2017.11.003","article-title":"Clinical, histological, immunological presentations and outcomes of bullous systemic lupus erythematosus: 10 new cases and a literature review of 118 cases","volume":"48","author":"de Risi-Pugliese","year":"2018","journal-title":"Semin Arthritis Rheum."},{"key":"10.1016\/j.abd.2022.09.005_bib0220","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2147\/CCID.S220906","article-title":"Vesiculobullous diseases in relation to lupus erythematosus","volume":"12","author":"Rutnin","year":"2019","journal-title":"Clin Cosmet Investig Dermatol."},{"key":"10.1016\/j.abd.2022.09.005_bib0225","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.annder.2020.08.052","article-title":"Lupus erythematosus: significance of dermatologic findings","volume":"148","author":"Lenormand","year":"2021","journal-title":"Ann Dermatol Venereol."},{"key":"10.1016\/j.abd.2022.09.005_bib0230","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.abd.2021.02.008","article-title":"Skin manifestations associated with systemic diseases - Part I","volume":"96","author":"Sampaio","year":"2021","journal-title":"An Bras Dermatol."},{"key":"10.1016\/j.abd.2022.09.005_bib0235","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/his.14440","article-title":"Cutaneous manifestations of lupus erythematosus: a practical clinicopathological review for pathologists","volume":"80","author":"Bitar","year":"2022","journal-title":"Histopathology."},{"key":"10.1016\/j.abd.2022.09.005_bib0240","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jaut.2014.01.021","article-title":"The classification and diagnosis of cutaneous lupus erythematosus","volume":"48-49","author":"Kuhn","year":"2014","journal-title":"J Autoimmun."},{"key":"10.1016\/j.abd.2022.09.005_bib0245","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.autrev.2008.12.014","article-title":"Histologic features of cutaneous lupus erythematosus","volume":"8","author":"Baltaci","year":"2009","journal-title":"Autoimmun Rev."},{"key":"10.1016\/j.abd.2022.09.005_bib0250","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1001\/jamadermatol.2021.3892","article-title":"Assessment of clinical and laboratory use of the cutaneous direct immunofluorescence assay","volume":"157","author":"Reimann","year":"2021","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.abd.2022.09.005_bib0255","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3389\/fimmu.2018.00541","article-title":"Autoantibodies associated with connective tissue diseases: what meaning for clinicians?","volume":"9","author":"Didier","year":"2018","journal-title":"Front Immunol."},{"key":"10.1016\/j.abd.2022.09.005_bib0260","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1080\/1744666X.2020.1805316","article-title":"New insights into the progression from cutaneous lupus to systemic lupus erythematosus","volume":"16","author":"Zhou","year":"2020","journal-title":"Expert Rev Clin Immunol."},{"key":"10.1016\/j.abd.2022.09.005_bib0265","doi-asserted-by":"crossref","first-page":"431","DOI":"10.21037\/atm-20-5048","article-title":"The CLASI, a validated tool for the evaluation of skin disease in lupus erythematosus: a narrative review","volume":"9","author":"Chakka","year":"2021","journal-title":"Ann Transl Med."},{"key":"10.1016\/j.abd.2022.09.005_bib0270","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/ced.14420","article-title":"Use of the Cutaneous Lupus Disease Area and Severity Index as an outcome measure in clinical trials: a descriptive study","volume":"46","author":"Mack","year":"2021","journal-title":"Clin Exp Dermatol."},{"key":"10.1016\/j.abd.2022.09.005_bib0275","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1016\/j.jisp.2017.02.001","article-title":"Cutaneous lupus: a brief review of old and new medical therapeutic options","volume":"18","author":"Nutan","year":"2017","journal-title":"J Investig Dermatol Symp Proc."},{"key":"10.1016\/j.abd.2022.09.005_bib0280","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/BOR.0000000000000704","article-title":"Treatment of cutaneous lupus erythematosus: current approaches and future strategies","volume":"32","author":"Shi","year":"2020","journal-title":"Curr Opin Rheumatol."},{"key":"10.1016\/j.abd.2022.09.005_bib0285","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.semarthrit.2019.07.010","article-title":"Management of cutaneous manifestations of lupus erythematosus: a systematic review","volume":"50","author":"Fairley","year":"2020","journal-title":"Semin Arthritis Rheum."},{"key":"10.1016\/j.abd.2022.09.005_bib0290","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2020-000430","article-title":"Candidate drug replacements for quinacrine in cutaneous lupus erythematosus","volume":"7","author":"Yan","year":"2020","journal-title":"Lupus Sci Med."},{"key":"10.1016\/j.abd.2022.09.005_bib0295","article-title":"Interventions for cutaneous disease in systemic lupus erythematosus","volume":"3","author":"Hannon","year":"2021","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.abd.2022.09.005_bib0300","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1007\/s40265-019-01151-8","article-title":"Current concepts and future approaches in the treatment of cutaneous lupus erythematosus: a comprehensive review","volume":"79","author":"Chasset","year":"2019","journal-title":"Drugs."},{"key":"10.1016\/j.abd.2022.09.005_bib0305","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/jdv.14053","article-title":"S2k guideline for treatment of cutaneous lupus erythematosus \u2013 guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV)","volume":"31","author":"Kuhn","year":"2017","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.abd.2022.09.005_bib0310","doi-asserted-by":"crossref","DOI":"10.1111\/dth.15034","article-title":"Treatments for disease damage in cutaneous lupus erythematosus: a narrative review","volume":"34","author":"Joseph","year":"2021","journal-title":"Dermatol Ther."},{"key":"10.1016\/j.abd.2022.09.005_bib0315","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1111\/1756-185X.14215","article-title":"Which interventions are effective for cutaneous disease in systemic lupus erythematosus? A Cochrane Review summary with commentary","volume":"24","author":"de Sire","year":"2021","journal-title":"Int J Rheum Dis."},{"key":"10.1016\/j.abd.2022.09.005_bib0320","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/bjd.15312","article-title":"Efficacy and comparison of antimalarials in cutaneous lupus erythematosus subtypes: a systematic review and meta-analysis","volume":"177","author":"Chasset","year":"2017","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.abd.2022.09.005_bib0325","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s42358-020-00134-8","article-title":"Revisiting hydroxychloroquine and chloroquine for patients with chronic immunity-mediated inflammatory rheumatic diseases","volume":"60","author":"Reis Neto","year":"2020","journal-title":"Adv Rheumatol."},{"key":"10.1016\/j.abd.2022.09.005_bib0330","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/annrheumdis-2019-215089","article-title":"2019 update of the EULAR recommendations for the management of systemic lupus erythematosus","volume":"78","author":"Fanouriakis","year":"2019","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.abd.2022.09.005_bib0335","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1590\/abd1806-4841.20142146","article-title":"Lupus erythematosus: considerations about clinical, cutaneous and therapeutic aspects","volume":"89","author":"Moura Filho","year":"2014","journal-title":"An Bras Dermatol."},{"key":"10.1016\/j.abd.2022.09.005_bib0340","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000441054","article-title":"Dapsone as second-line treatment for cutaneous lupus erythematosus? A retrospective analysis of 34 patients and a review of the literature","volume":"232","author":"Klebes","year":"2016","journal-title":"Dermatology."},{"key":"10.1016\/j.abd.2022.09.005_bib0345","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/RHU.0000000000001160","article-title":"Thalidomide and lenalidomide for refractory systemic\/cutaneous lupus erythematosus treatment: a narrative review of literature for clinical practice","volume":"27","author":"Yuki","year":"2021","journal-title":"J Clin Rheumatol."},{"key":"10.1016\/j.abd.2022.09.005_bib0350","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jaad.2017.09.059","article-title":"Efficacy and tolerance profile of thalidomide in cutaneous lupus erythematosus: a systematic review and meta-analysis","volume":"78","author":"Chasset","year":"2018","journal-title":"J Am Acad Dermatol."}],"container-title":["Anais Brasileiros de Dermatologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059623000247?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059623000247?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T23:42:38Z","timestamp":1759794158000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0365059623000247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":70,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S0365059623000247"],"URL":"https:\/\/doi.org\/10.1016\/j.abd.2022.09.005","relation":{},"ISSN":["0365-0596"],"issn-type":[{"value":"0365-0596","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cutaneous lupus erythematosus: a review of etiopathogenic, clinical, diagnostic and therapeutic aspects","name":"articletitle","label":"Article Title"},{"value":"Anais Brasileiros de Dermatologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abd.2022.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Sociedade Brasileira de Dermatologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}